TPW
ABBV icon

Turn8 Private Wealth’s AbbVie ABBV Stock Holding History

Turn8 Private Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$201K Buy
+800
New +$172K 0.13% 48
2025
Q2 		– Sell
-1,000
Closed -$210K – 45
2025
Q1 		$210K Sell
1,000
-830
-45% -$161K 0.16% 50
2024
Q4 		$325K Buy
+1,830
New +$336K 0.23% 42

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Turn8 Private Wealth's ABBV Position: Q2 2026 in Review

Turn8 Private Wealth opened a new position in AbbVie (ABBV) in Q2 2026: 800 shares worth $201K. The stake represents 0.13% of the portfolio and ranks #48 among its holdings. This is a return to the name: Turn8 Private Wealth previously reported a position in ABBV as recently as Q1 2025.

Turn8 Private Wealth first reported a position in ABBV in Q4 2024 and has held it in 3 quarters since. The position peaked at $325K in Q4 2024. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Turn8 Private Wealth held 800 shares of AbbVie worth $201K as of Q2 2026.
  • AbbVie was a new Turn8 Private Wealth position in Q2 2026.
  • AbbVie made up 0.13% of Turn8 Private Wealth's portfolio in Q2 2026, its #48 holding.
  • Turn8 Private Wealth first reported a position in AbbVie in Q4 2024 and has held it in 3 quarters since.
  • Turn8 Private Wealth's AbbVie position peaked at $325K in Q4 2024.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Turn8 Private Wealth's 13F filing for Q2 2026, filed 3 Aug 2026.